A hypothalamic vasopressinergic pathway mediates the sympathoexcitation induced by hyperosmolality

University College London 2006 (2006) Proc Physiol Soc 3, PC85

Poster Communications: A hypothalamic vasopressinergic pathway mediates the sympathoexcitation induced by hyperosmolality

Vagner Roberto Antunes1, Song T Yao1, Anthony E Pickering2, David Murphy1, Julian FR Paton2

1. Henry Wellcome LINE, University of Bristol, Bristol, United Kingdom. 2. Physiology, Bristol Heart Institute, University of Bristol, Bristol, United Kingdom.

View other abstracts by:


An osmotic challenge elicits a sympathoexcitatory response that involves hypothalamic projections to the intermediolateral cell column (IML) of the spinal cord [1]. Moreover, fibres immunoreactive for vasopressin make up an abundant terminal network in the IML [2], which has been associated with sympathoexcitation [3,4]. Using a novel in situ rat preparation, we sought to investigate whether hypothalamic vasopressinergic spinally projecting neurones are activated during acute increases in plasma osmolality to elicit sympathoexcitation. Male Wistar rats (70-90 g) were anaesthetised deeply with halothane (5%) and decorticated, which included removal of the thalamus but preserved hypothalamic structures. Animals were arterially perfused with Ringer solution containing Ficoll (1.25%) at 31°C. Via a suction electrode lumbar sympathetic nerve activity (LSNA) was monitored while switching the perfusate from being isosmotic (291±1 mosmol (kg water)–1) to hyperosmotic (321±1 mosmol (kg water)–1) over 40s. For intrathecal injections, a calibrated glass micropipette was positioned into the subarachnoid space and a volume of up to 0.5 μl was delivered. Initially, we evaluated the response of intrathecal injections of a V1 receptor agonist (Phe2,Ile3,Orn8-Vasopressin; 1 μg ml–1) on LSNA before and after intrathecal injections of a V1a receptor antagonist (β-mercapto-β-β-cyclopentamethylenepropionyl1,O-me-Tyr2,-Arg8-Vasopressin; 1 μg ml–1). The V1 receptor agonist induced sympathoexcitation (18±1%; n=3). This increase in LSNA was attenuated significantly by prior intrathecal delivery of a V1a receptor antagonist to 6±2% (P<0.05, n=3). This dose of antagonist was then used to assess the hyperosmotic perfusate induced increase in LSNA. In control, hyperosmotic perfusate increased LSNA by 29±6% (n=5) but this was attenuated reversibly to 4±1% (P<0.001, n=5) at 2 min after intrathecal injection of the V1a receptor antagonist (1 μg ml–1). Thirty minutes later the hyperosmotic-induced increase in LSNA had recovered to control levels (25±3%). Our findings demonstrate the functional importance of the spinally projecting vasopressinergic pathway from the hypothalamus. This acts to stimulate spinal V1a receptors and mediate the sympathoexcitation following acute salt loading.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type